ZDA
ARQT icon

Zweig-DiMenna Associates’s Arcutis Biotherapeutics ARQT Stock Holding History

Zweig-DiMenna Associates’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-41,500
Closed -$578K – 67
2024
Q4 		$578K Buy
+41,500
New +$578K 0.04% 87